To explore the biological roles of FTO in breast cancer malignancy, we introduced shRNA-mediated FTO knockdown (KD) (shFTO#1, #2, and #3) into MDA-MB-231 and BT-549 cells (Fig. 1G and S1B-C). This evidence concerns the gene FTO and breast cancer.